Smart goals and continuous improvement for a resilient sustainability strategy
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Smart goals and continuous improvement for a resilient sustainability strategy

28 Apr 2021 (Last Updated April 28th, 2021 17:28)

Sponsored by Datwyler Sponsored by Visit Company
Smart goals and continuous improvement for a resilient sustainability strategy

Forecasts on the effects of climate change have prompted all industries, including the pharmaceutical sector, to implement more environmentally responsible practices. In doing so, in 2015, some of the biggest names in the pharmaceutical industry, including Patheon, Biogen, Johnson & Johnson, Genentech, and Novartis joined the American Business Act on Climate Pledge. Just last year, the European Commission (EC) outlined a strategic approach to pharmaceuticals in the environment which included expanding environmental monitoring, improving environmental risk assessment, supporting greener manufacturing methods, and reducing as well as better managing waste.   

Now, even as the industry remains focused on the development and production of viable COVID-19 vaccines and treatments, drug manufacturers can continue to support sustainability initiatives by working with suppliers aligned with their commitments to build a more eco-conscious supply chain. Many already are by utilizing principles and implementation guidance. Others are taking even larger steps. For example, Pfizer announced in March the completion of a $1.25 billion 10-year sustainability bond that will mature April 1, 2030—a first-ever sustainability bond for Pfizer—or any biopharmaceutical company. Proceeds from the bond will help support patient access to Pfizer’s medicines as well as support the company’s robust sustainability efforts aimed at significant reductions in greenhouse gas emissions, waste and water use. However, particularly for parenteral drug packaging, there are some key considerations to make when specifying solutions like plungers for pre-filled syringes and stoppers and caps for vials. How these system-critical elastomer components are manufactured makes up part of the sustainability story for every drug manufacturer.  

Smart resource management for a resilient sustainability strategy

In July, Datwyler announced its long-term target for carbon neutrality after successfully reducing consumption of electricity, fuels, and water per revenue unit for three consecutive years. Last year marked several key strides in resource management. The company reduced consumption per revenue unit for: electricity (-3.2 percent), fuels (-0.5 percent), water (-15.0 percent), and waste volume (-5.5 percent).  

Even though the company contends with the industry-wide challenges posed by Covid-19, Datwyler’s interdisciplinary project group continues advancing its sustainability and climate strategy with the long-term goal of carbon neutrality. In Switzerland, Datwyler produces CO2 neutrally by utilising a wood-fired heating plant for process energy and heating power as well as hydropower for electricity. As a result, every year the company saves 500,000 tonnes of fuel oil and 3,600 tonnes of CO2. By implementing and operating a modern trigeneration unit at the Italian facility, Datwyler reduces the CO2 emissions by some additional 900 tonnes per year.  

These resource management changes help the company do its part in meeting the United Nations (UN) Sustainable Development Goals. The efforts also merited Datwyler a top 25 percent ranking in the EcoVadis CSR audit. As a company that continues to balance sustainability goals with the demands of designing and producing system-critical elastomer components for the primary packaging of parenteral drugs—meeting the highest standards for inertness, particle contamination prevention, and compatibility with highly-sensitive large molecule formulations—Datwyler continuously improves the ways it can help pharmaceutical customers build a more resilient, environmentally conscious supply chain.

  

1.Compliance with credible sustainability standards and goal setting organizations

Demonstrating alignment with initiatives such as the United Nations (UN) Global Compact, a voluntary initiative based on CEO commitments to implement universal sustainability principles and take steps to support UN goals, or the Global Reporting Initiative (GRI), an independent international organization that has pioneered sustainability for more than 20 years, reaffirms Datwyler’s commitment and drives continuous improvement. As early as 2008, Datwyler has published an annual sustainability report in accordance with the GRI guidelines. And since 2009 the Swiss based healthcare supplier has been a member of the UN Global Compact. The Carbon Disclosure Project (CDP) is another example. The not-for-profit charity runs the global disclosure system for investors, companies, cities, states and regions to manage their environmental impacts. EcoVadis is one of the world’s leading companies for corporate social responsibility (CSR) audits. It has assessed 60,000 companies from 155 countries, awarding performance ratings based on audits by sustainability experts. In addition to assigning rankings, EcoVadis offers industry profiles to improve performance.  

Outside of sustainability-driven organizations, specific certifications from the International Organization for Standardization (ISO), including 14001, 50001, and OHSAS 18001) also provide important benchmarks. ISO 14001 is the international standard specifying requirements for an effective environmental management system (EMS). ISO 50001 is a company level certification requiring use of an energy management system. This standard calls for the company to develop an energy policy, establish goals for energy efficiency, utilise data to meet said goals, measure policy effectiveness, and make continuous improvements to the policy. These and other standards and organizations make for a robust guiding force for developing or reconfiguring sustainability goals. 

2.Incremental goal setting to reduce utility usage and waste

Over three consecutive years, Datwyler managed reductions in resource consumption across key areas. Electricity consumption declined 6.9 MWh per million CHF in revenue and CO2 emissions declined 5.6 tonnes per million CHF in revenue compared to the previous year. Additionally, water consumption declined by 184,799 m³ compared to the previous year and waste declined by 900 kg per million CHF compared to the previous year. To achieve this progress, Datwyler set challenging but achievable targets based on average annual reduction in the relative consumption of resources per revenue unit up to 2020: fuel –6 percent, electricity –3 percent, water –3 percent, volume of waste –3 percent.  

3.Evaluation of Chemical Compliance Management

Manufacturing 30 billion components a year requires 56,000 tonnes of raw materials like polymers, fillers, aluminium, curing agents, and antioxidants. As such, Datwyler must meet a variety of chemical law requirements at its production locations around the world as well as additional industry and customer-specific rules. Chemicals legislation and the EU REACH (EU Regulation 1907/2006) governs the registration, assessment and approval of chemical substances within the European Union, setting the standard for compliance. However, proactive advancements in chemical compliance management help to keep companies ahead of the curve on best practices for raw materials sourcing, usage, handling, and disposal. Ensuring transparency on all substances makes seamless, open communication between customers and suppliers easier, especially if previously unproblematic substances must be re-evaluated (even if they continue to meet regulatory standards). In an instance where a particular material or ingredient is no longer desirable, implementing new solutions sooner rather than later could minimise product waste in the long run. Other important considerations for effective (raw) material management include the forwarding of waste rubber material for safe reuse and efforts to curb packaging waste or switch to recyclable or even reusable packaging materials. 

4.Investment in Green Electricity to Support Carbon Neutrality

In addition to reducing overall energy and utility consumption, employing carbon-neutral electricity makes hitting major sustainability goals a stronger possibility for larger companies with global operations. So in addition to the steps taken toward carbon neutrality at Datwyler’s Switzerland and Italy plants, the company works on a plan to purchase carbon-neutral electricity at all its plants worldwide

There is no time like the present to plan a better future

When it comes to driving sustainability in the pharmaceutical industry, the road ahead will be long. Last year, a study published in the Journal of Cleaner Production claimed the pharma industry generated greenhouse gas emissions 55 percent greater than that of the automotive industry in 2015. The paper, “Carbon footprint of the global pharmaceutical industry and relative impact of its major players” asserted that the sector would need to reduce emissions by 58.6 percent, from 2015 levels by 2025 to comply with reduction targets in the Paris Agreement.  

However, from parenteral packaging components manufacturers to drug companies, the industry is in this together. Even in the most challenging times, setting and acting on goals for sustainable initiatives is a promise to do even better for the patients that both rely on the medications produced and must live in the world where they are made. By constructively working together, drug companies and its suppliers can develop more resilient, long-term strategies that contribute to worldwide sustainability goals and help combat climate change—even amid a pandemic.  

Datwyler is prepared to make its contribution as a socially and environmentally responsible company. There is only one planet and we have to take good care of it if we want to secure it for our children and future generations. Datwyler proudly looks back on more than 100 years of value creation for the benefit of all its stakeholders. Sustainability is deeply rooted in our heritage and values and has always been part of the DNA of the company. Eleven years of membership in the UN Global Compact and twelve GRI sustainability reports prove our commitment. Despite the pandemic, Datwyler is continuing its efforts. An interdisciplinary project group is working on further advancing the sustainability and climate strategy with the long-term target of becoming carbon neutral. Specific milestones will be communicated with the next sustainability report in spring 2021. Adhering to the “People, Planet, Profit” concept, Datwyler wants to live up to its social responsibility, offer an attractive and agile work environment and attract the best international talent. Aware that resources are limited, we want to use them responsibly and contribute to achieving the UN Sustainable Development Goals. And above all, we want to continue to create value for our customers, grow profitably and lay the foundation for our longterm success. 

Free Whitepaper

FirstLine: Datwyler’s Most Advanced Manufacturing Standard

Datwyler is a provider of innovative and effective elastomer components for the pharmaceutical and biotech markets’ packaging needs, with a focus on quality and safety at all times. For high-end markets that require the absolute best-in-class sealing solutions for their drug products, Datwyler introduced its most advanced manufacturing standard: FirstLine. The FirstLine manufacturing environment is a fully integrated cleanroom that conforms to the highest of industry standards. A strict zero-defect philosophy is what makes FirstLine the best choice for customers seeking the highest quality and safest components. This whitepaper explores the state-of-the-art features of the FirstLine environment, explaining how it ensures contaminant and defect-free production for high-end drug products.

By clicking the “Submit” button above, you accept the Terms & Conditions and acknowledge that your data will be used as described in the Datwyler Privacy Policy.

We will also collect and use the information you provide for carefully considered and specific purposes, where we believe we have a legitimate interest in doing so, for example to send you communications about similar products and services we offer. We will always give you an option to opt out of any future communications from us. You can find out more about our legitimate interest activity in our privacy policy here. ‘We’ includes Verdict Media Limited and other GlobalData brands as detailed here.